S Papapoulos
Overview
Explore the profile of S Papapoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masi L, Ferrari S, Javaid M, Papapoulos S, Pierroz D, Brandi M
Orphanet J Rare Dis
. 2021 Jan;
16(1):11.
PMID: 33407701
Background: Bone tissue represents a large systemic compartment of the human body, with an active metabolism, that controls mineral deposition and removal, and where several factors may play a role....
2.
McCloskey E, Rathi J, Heijmans S, Blagden M, Cortet B, Czerwinski E, et al.
Osteoporos Int
. 2020 Aug;
32(2):251-259.
PMID: 32829471
Introduction: Treatment rates in osteoporosis are documented to be low. We wished to assess the osteoporosis treatment gap in women ≥ 70 years in routine primary care across Europe. Methods:...
3.
Kendler D, Chines A, Brandi M, Papapoulos S, Lewiecki E, Reginster J, et al.
Osteoporos Int
. 2018 Sep;
30(1):71-78.
PMID: 30244369
Introduction: This analysis assessed whether a fracture sustained during denosumab therapy indicates inadequate treatment response and if the risk of a subsequent fracture decreases with continuing denosumab treatment. Methods: In...
4.
Diez-Perez A, Bouxsein M, Eriksen E, Khosla S, Nyman J, Papapoulos S, et al.
Bone Rep
. 2016 Dec;
5:181-185.
PMID: 27975078
Impact microindentation is a novel method for measuring the resistance of cortical bone to indentation in patients. Clinical use of a handheld impact microindentation technique is expanding, highlighting the need...
5.
Masi L, Agnusdei D, Bilezikian J, Chappard D, Chapurlat R, Cianferotti L, et al.
Osteoporos Int
. 2015 Sep;
26(11):2717-8.
PMID: 26370825
No abstract available.
6.
Bone H, Dempster D, Eisman J, Greenspan S, McClung M, Nakamura T, et al.
Osteoporos Int
. 2015 Sep;
26(11):2721.
PMID: 26359183
No abstract available.
7.
Papapoulos S, Lippuner K, Roux C, Lin C, Kendler D, Lewiecki E, et al.
Osteoporos Int
. 2015 Jul;
26(12):2773-83.
PMID: 26202488
Unlabelled: The FREEDOM study and its Extension provide long-term information about the effects of denosumab for the treatment of postmenopausal osteoporosis. Treatment for up to 8 years was associated with...
8.
Masi L, Agnusdei D, Bilezikian J, Chappard D, Chapurlat R, Cianferotti L, et al.
Osteoporos Int
. 2015 Jun;
26(10):2529-58.
PMID: 26070300
Unlabelled: This article reports a taxonomic classification of rare skeletal diseases based on metabolic phenotypes. It was prepared by The Skeletal Rare Diseases Working Group of the International Osteoporosis Foundation...
9.
Bone H, Dempster D, Eisman J, Greenspan S, McClung M, Nakamura T, et al.
Osteoporos Int
. 2014 Nov;
26(2):699-712.
PMID: 25432773
Summary: Odanacatib is a cathepsin K inhibitor investigated for the treatment of postmenopausal osteoporosis. Phase 2 data indicate that 50 mg once weekly inhibits bone resorption and increases bone mineral...
10.
Kanis J, McCloskey E, Branco J, Brandi M, Dennison E, Devogelaer J, et al.
Osteoporos Int
. 2014 Sep;
25(11):2533-43.
PMID: 25199574
Unlabelled: Despite the proven predictive ability of bone mineral density, Fracture Risk Assessment Tool (FRAX®), bone turnover markers, and fracture for osteoporotic fracture, their use as targets for treatment of...